Houston has earned its reputation as a destination for cancer care. But for patients in the Bay Area, access is not just ...

Traws Pharma, Inc. (NASDAQ: TRAW, the Company), a clinical-stage biopharmaceutical company developing novel therapies for critical global viral threats, today announced that ...

The SBA's 8 (a) program is getting new attention from the Trump administration. The agency said it wants to end what it calls ...

Going into her junior year of high school, Raynbow Carter/Freeman described herself as “lost.” In 2023, the teenager’s mother ...

Lian is a next-generation, high-precision program analysis framework designed for multi-language environments. It aims to deliver unified and powerful program analysis capabilities across diverse ...

Collaboration will evaluate Scenic's first-in-class PLA2G15 inhibitor program in Parkinson's diseaseLeveraging MJFF’s LITE consortium and world-class LRRK2 biology and biomarker infrastructure to test ...

Reserves in the hospital trust fund, built up over decades, are forecast to be depleted in 2033 — but one quarter earlier ...